Vericel Corp Ord (VCEL NASDAQ) stock market data APIs
$37.3534
-1.61(-4.3%)
as of November 5, 2025
Try our APIs with
free plan!
Vericel Corp Ord Financial Data Overview
Price chart is built with
Anychart
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Prev. Close
37.3534
Open
35.7422
High
37.0648
Low
35.6446
52 wk Range
29.24-63
Market Cap
1 829 M
P/E Ratio
258.9286
Shares Outstanding
50 460 K
Revenue
249 M
EPS
0
Beta
1.218
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Vericel Corp Ord (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vericel Corp Ord data using free add-ons & libraries
Get Vericel Corp Ord Fundamental Data
Vericel Corp Ord Fundamental data includes:
- Net Revenue: 249 M
- EBITDA: 9 508 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: -0.0063
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vericel Corp Ord News
New
Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?
Shares of Emergent Biosolutions (EBS) have been strong performers lately, with the stock up 39.7% over the past month. The stock hit a new 52-week high of $13.41 in the previous session. Emergent Bios...
Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025
Vericel Corporation CAMBRIDGE, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today a...
Here’s Why Vericel Corporation (VCEL) Underperformed in Q3
Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their momentum that beg...
Exploring High Growth Tech Stocks In The US Market
As the U.S. stock market experiences a surge, with key indices like the Nasdaq and S&P 500 posting significant gains, investors are closely monitoring high-growth tech stocks that continue to capture ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
